• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于测量疟疾传播阻断或减少活性的标准膜饲法的统计方法

Statistical Methods for Standard Membrane-Feeding Assays to Measure Transmission Blocking or Reducing Activity in Malaria.

作者信息

Swihart Bruce J, Fay Michael P, Miura Kazutoyo

机构信息

Biostatistics Research Branch, NIAID, NIH, Rockville, MD.

National Institute of Allergy and Infectious Diseases, Laboratory of Malaria and Vector Research, National Institutes of Health, Rockville, MD.

出版信息

J Am Stat Assoc. 2018;113(522):534-545. doi: 10.1080/01621459.2017.1356313. Epub 2018 Jun 12.

DOI:10.1080/01621459.2017.1356313
PMID:31007315
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6469714/
Abstract

Transmission blocking vaccines for malaria are not designed to directly protect vaccinated people from malaria disease, but to reduce the probability of infecting other people by interfering with the growth of the malaria parasite in mosquitoes. Standard membrane-feeding assays compare the growth of parasites in mosquitoes from a test sample (using antibodies from a vaccinated person) compared to a control sample. There is debate about whether to estimate the transmission reducing activity (TRA) which compares the mean number of parasites between test and control samples, or transmission blocking activity (TBA) which compares the proportion of infected mosquitoes. TBA appears biologically more important since each mosquito with any parasites is potentially infective; however, TBA is less reproducible and may be an overly strict criterion for screening vaccine candidates. Through a statistical model, we show that the TBA estimand depends on , the mean number of parasites in the control mosquitoes, a parameter not easily experimentally controlled. We develop a standardized TBA estimator based on the model and a given target value for which has better mean squared error than alternative methods. We discuss types of statistical inference needed for using these assays for vaccine development.

摘要

疟疾传播阻断疫苗并非旨在直接保护接种疫苗的人免受疟疾疾病侵害,而是通过干扰疟原虫在蚊子体内的生长来降低感染他人的可能性。标准膜饲试验将测试样本(使用来自接种疫苗者的抗体)中蚊子体内寄生虫的生长情况与对照样本进行比较。关于是估计比较测试样本和对照样本之间寄生虫平均数量的传播减少活性(TRA),还是比较受感染蚊子比例的传播阻断活性(TBA),存在争议。TBA在生物学上似乎更重要,因为每只带有任何寄生虫的蚊子都有潜在传染性;然而,TBA的可重复性较差,可能是筛选候选疫苗的过于严格标准。通过一个统计模型,我们表明TBA估计量取决于对照蚊子体内寄生虫的平均数量 ,这是一个不易通过实验控制的参数。我们基于该模型和给定的 目标值开发了一种标准化的TBA估计器,其均方误差比其他方法更好。我们讨论了将这些试验用于疫苗研发所需的统计推断类型。

相似文献

1
Statistical Methods for Standard Membrane-Feeding Assays to Measure Transmission Blocking or Reducing Activity in Malaria.用于测量疟疾传播阻断或减少活性的标准膜饲法的统计方法
J Am Stat Assoc. 2018;113(522):534-545. doi: 10.1080/01621459.2017.1356313. Epub 2018 Jun 12.
2
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.在恶性疟原虫标准膜饲实验中,传播阻断活性由传播减少活性和对照卵囊数量共同决定。
Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.
3
A randomized feasibility trial comparing four antimalarial drug regimens to induce gametocytemia in the controlled human malaria infection model.一项比较四种抗疟药物方案诱导人体疟疾感染模型配子体血症的随机可行性试验。
Elife. 2018 Feb 27;7:e31549. doi: 10.7554/eLife.31549.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.用于评估疫苗和药物对恶性疟原虫传播阻断活性的稳健、可重复、工业化标准膜饲法。
Malar J. 2015 Apr 9;14:150. doi: 10.1186/s12936-015-0665-8.
6
Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines.评价和建立恶性疟原虫直接膜 feeding 检测方法以支持传播阻断疫苗的研发。
Sci Rep. 2020 Jul 28;10(1):12569. doi: 10.1038/s41598-020-69513-x.
7
Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.疟疾候选疫苗Pfs25/Pvs25诱导的传播阻断活性是抗体滴度的直接且可预测的函数。
Malar J. 2007 Aug 8;6:107. doi: 10.1186/1475-2875-6-107.
8
Strong concordance between percent inhibition in oocyst and sporozoite intensities in a Plasmodium falciparum standard membrane-feeding assay.在恶性疟原虫标准膜饲检测中,卵囊和子孢子强度的抑制率之间具有高度一致性。
Parasit Vectors. 2019 May 6;12(1):206. doi: 10.1186/s13071-019-3470-3.
9
Comparative assessment of An. gambiae and An. stephensi mosquitoes to determine transmission-reducing activity of antibodies against P. falciparum sexual stage antigens.比较评估冈比亚按蚊和斯蒂芬斯按蚊,以确定针对疟原虫有性阶段抗原的抗体的传播减少活性。
Parasit Vectors. 2017 Oct 17;10(1):489. doi: 10.1186/s13071-017-2414-z.
10
Consistency and reproducibility of independent feedings using blood from two consecutive days at varying Plasmodium falciparum gametocyte densities based on both direct membrane feeding assay and direct skin feeding assay.基于直接膜饲法和直接皮肤饲法,在不同恶性疟原虫配子体密度下,使用连续两天的血液进行独立饲育的一致性和可重复性。
Malar J. 2025 May 16;24(1):154. doi: 10.1186/s12936-025-05360-3.

引用本文的文献

1
Transmission-Blocking Vaccines: Harnessing Herd Immunity for Malaria Elimination.阻断传播疫苗:利用群体免疫消除疟疾。
Expert Rev Vaccines. 2021 Feb;20(2):185-198. doi: 10.1080/14760584.2021.1878028. Epub 2021 Jan 31.
2
Evaluation and modeling of direct membrane-feeding assay with Plasmodium vivax to support development of transmission blocking vaccines.评价和建立恶性疟原虫直接膜 feeding 检测方法以支持传播阻断疫苗的研发。
Sci Rep. 2020 Jul 28;10(1):12569. doi: 10.1038/s41598-020-69513-x.
3
Structure and function of a malaria transmission blocking vaccine targeting Pfs230 and Pfs230-Pfs48/45 proteins.疟疾传播阻断疫苗靶向 Pfs230 和 Pfs230-Pfs48/45 蛋白的结构与功能。
Commun Biol. 2020 Jul 24;3(1):395. doi: 10.1038/s42003-020-01123-9.
4
Cryogenically preserved RBCs support gametocytogenesis of Plasmodium falciparum in vitro and gametogenesis in mosquitoes.冷冻保存的 RBC 支持疟原虫 falciparum 的配子发生体外和蚊子中的配子发生。
Malar J. 2018 Dec 6;17(1):457. doi: 10.1186/s12936-018-2612-y.
5
Predictive cluster level surrogacy in the presence of interference.存在干扰时的预测性簇级替代。
Biostatistics. 2020 Apr 1;21(2):e33-e46. doi: 10.1093/biostatistics/kxy050.
6
Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay.在恶性疟原虫标准膜饲实验中,传播阻断活性由传播减少活性和对照卵囊数量共同决定。
Vaccine. 2016 Jul 29;34(35):4145-4151. doi: 10.1016/j.vaccine.2016.06.066. Epub 2016 Jun 29.

本文引用的文献

1
Transmission-blocking activity of antibodies to Plasmodium falciparum GLURP.10C chimeric protein formulated in different adjuvants.恶性疟原虫谷氨酸富蛋白10C嵌合蛋白在不同佐剂中配制时抗体的传播阻断活性。
Malar J. 2015 Nov 9;14:443. doi: 10.1186/s12936-015-0972-0.
2
Transmission blocking malaria vaccines: Assays and candidates in clinical development.传播阻断型疟疾疫苗:临床开发中的检测方法与候选疫苗
Vaccine. 2015 Dec 22;33(52):7476-82. doi: 10.1016/j.vaccine.2015.08.073. Epub 2015 Sep 26.
3
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial.RTS,S/AS01疟疾疫苗的免疫原性及其对疫苗效力持续时间的影响:一项3期随机对照试验数据的二次分析
Lancet Infect Dis. 2015 Dec;15(12):1450-8. doi: 10.1016/S1473-3099(15)00239-X. Epub 2015 Sep 2.
4
Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles.使用恶性疟原虫抗原Pfs25附着的金纳米颗粒的疟疾纳米疫苗。
Vaccine. 2015 Sep 22;33(39):5064-71. doi: 10.1016/j.vaccine.2015.08.025. Epub 2015 Aug 20.
5
Development of malaria transmission-blocking vaccines: from concept to product.疟疾传播阻断疫苗的研发:从概念到产品
Adv Parasitol. 2015 Jun;89:109-52. doi: 10.1016/bs.apar.2015.04.001. Epub 2015 May 8.
6
Alga-produced malaria transmission-blocking vaccine candidate Pfs25 formulated with a human use-compatible potent adjuvant induces high-affinity antibodies that block Plasmodium falciparum infection of mosquitoes.用与人用兼容的强效佐剂配制的藻类产生的疟疾传播阻断疫苗候选物Pfs25可诱导高亲和力抗体,这些抗体可阻断恶性疟原虫对蚊子的感染。
Infect Immun. 2015 May;83(5):1799-808. doi: 10.1128/IAI.02980-14. Epub 2015 Feb 17.
7
Design of a Phase III cluster randomized trial to assess the efficacy and safety of a malaria transmission blocking vaccine.一项评估疟疾传播阻断疫苗疗效和安全性的III期整群随机试验设计
Vaccine. 2015 Mar 24;33(13):1518-26. doi: 10.1016/j.vaccine.2015.01.050. Epub 2015 Feb 10.
8
A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.一种新型植物生产的Pfs25融合亚单位疫苗可诱导持久的传播阻断抗体反应。
Hum Vaccin Immunother. 2015;11(1):124-32. doi: 10.4161/hv.34366. Epub 2014 Nov 1.
9
Combining one-sample confidence procedures for inference in the two-sample case.在双样本情形下结合单样本置信程序进行推断。
Biometrics. 2015 Mar;71(1):146-156. doi: 10.1111/biom.12231. Epub 2014 Oct 1.
10
Development of a transmission-blocking malaria vaccine: progress, challenges, and the path forward.阻断疟疾传播疫苗的研发:进展、挑战和未来方向。
Vaccine. 2014 Sep 29;32(43):5531-9. doi: 10.1016/j.vaccine.2014.07.030. Epub 2014 Jul 29.